FDA inspection
Tyrone McCall, M.D.: FDA inspection ending Sep 19, 2022
FDA inspection 1180442 · Official Action Indicated (OAI) · Dallas, TX
Key facts
| Inspection ID | 1180442 |
|---|---|
| Firm | Tyrone McCall, M.D. |
| FEI number | 3020491814 |
| Address | 10740 N Central Expy Ste 350 |
| City | Dallas |
| State | TX |
| ZIP | 75231 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Sep 19, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
| Warning letter | 651261 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data